SpaceX IPO'd at $135. It Closed at $161. Now You Have to Decide.

The largest initial public offering in history closed yesterday. SpaceX (SPCX) priced at $135 per share on June 11, opened at $150 the following morning, and by the end of trading on June 12 stood at $161—a 19% gain from the IPO price in a single session. At the intraday peak, the stock was up more than 30%.

Retail investors were not spectators. SpaceX deliberately allocated approximately 30% of its shares to individual investors—roughly three times the typical allocation for a mega-cap offering. Retail orders exceeded $100 billion before the market even opened. According to Vanda Research data cited by Yahoo Finance, retail buying in SPCX ran at 3.5 times the pace of Nvidia at its most hyped moment. The company raised $75 billion total, the largest single-session fundraise in market history, surpassing Saudi Aramco. If you have a brokerage account at Fidelity, Schwab, Robinhood, SoFi, or E-Trade, there was a seat at this table. Now you have to decide what to do with it.

The Biggest IPO in History Is Now a Personal Finance Question

The decision in front of most retail investors is not whether SpaceX will eventually be worth something. The company generated $18.7 billion in revenue in 2025. It has Starlink, Starship, and a government contract pipeline most aerospace companies would not turn away. The long-term thesis is not what’s hard to evaluate.

What’s hard is the math of entry. SpaceX lost $8.7 billion over the 15 months ending in Q1 2026. At $161 per share—at a market cap that now exceeds $2 trillion—you are not buying a cheap asset with room to grow on current fundamentals. You are buying a bet on a future that has not arrived yet. A University of Florida IPO researcher cited by capital.com put it plainly: “SpaceX might be a great company, but a great company is not the same thing as a great stock.” An analyst quoted by Yahoo Finance gave a matching warning: “The stock is bound to be volatile—investors should consider timing their entry as the equity price settles down.”

That word—timing—is doing a lot of work. Because how you time your entry into a volatile position is a financial strategy question. It has nothing to do with what you think of Elon Musk.

What the DCA Simulator Tells You That the Hype Doesn't

When a stock jumps 19% in a single day and peaks intraday at 30%, two things happen at once. The investors who got IPO allocation at $135 feel validated. Everyone who missed allocation—or hesitated—now faces a different question: do you buy into the momentum, or do you wait?

The mathematically disciplined answer to that question is neither. It’s spread.

Dollar-cost averaging into a volatile position—buying a fixed dollar amount on a regular schedule rather than committing everything at once—does not maximize returns if the stock goes straight up. But SPCX will not go straight up. No single-name position with a $2 trillion valuation, a 30%+ first-day swing, and no established earnings record trades in one direction. When the price falls, DCA means you acquire more shares at a lower average cost. When it rebounds, your basis is better than the investor who went all-in at $161 on day one. For a deeper look at how this plays out across price scenarios, see our full breakdown of DCA versus lump sum in volatile markets.

Time in the market is the stronger bet—not timing the market. DCA keeps you invested through whichever price path arrives, rather than waiting for a moment that may not come.

That is not a SpaceX conclusion. It is the conclusion that applies to every high-profile, high-volatility entry point you will face as an investor.

Your Risk Tolerance Isn't What You Think It Is Right Now

Here is what the June 12 data actually tells you about retail investor behavior: SPCX buying ran at 3.5 times the pace of Nvidia at peak enthusiasm. That is a statistical marker of euphoria-driven purchasing. Millions of people saw green numbers, opened their brokerage apps, and bought more. That behavior is not investing in the traditional sense. It is FOMO—fear of missing out—dressed in a brokerage confirmation screen.

FOMO is not a character flaw. It is a predictable human response to a recent, salient price signal. What just happened feels like what will keep happening. Psychologists call it recency bias, and the research on it is unambiguous: assets purchased at intraday peaks have measurably worse forward returns than assets purchased at the prior day’s close. Not because the asset is bad—but because the buyer paid a temporary premium driven by attention rather than analysis. Single-name volatility of this kind is the same dynamic we covered in the AI concentration risk piece: when buying is driven by narrative rather than valuation, the gap between enthusiasm and outcome can be wide.

The check on FOMO is not willpower. It is self-knowledge. Specifically: understanding the gap between the risk tolerance you imagine you have and the risk tolerance you actually have.

Run the Risk Tolerance Quiz before making another move in SPCX. The quiz asks how you’ve responded to past drawdowns—hold, sell, or buy more? It asks about your time horizon. It produces a profile of your actual risk appetite, calibrated to your real behavior, not the behavior you think you’d have in a hypothetical. If your profile returns conservative, and you just bought a $2 trillion unprofitable company because it was up 19% on its debut, you have a mismatch. The quiz doesn’t tell you to sell. It tells you something more useful: whether the size of your position is something your actual self can hold if SPCX drops to $120 in August. Or $90.

What Most People Get Wrong About IPO Moments

The mistake is not buying the stock. The mistake is treating the buy decision as a SpaceX decision when it is actually a process decision.

The investors who profit most from IPO opportunities are rarely the ones who moved fastest. They are the ones who had a position-sizing rule before the IPO priced. Who knew, in advance, how much of their portfolio they were comfortable allocating to a single name at a $2 trillion valuation with eight-figure operating losses. Who had a plan for what to do if SPCX fell 30% in the first 90 days—because that is what high-profile IPOs do at rates that the first-day hype never advertises.

SpaceX may be one of the great investments of this decade. It may also spend two years oscillating between $100 and $180 while the company works through its path to profitability. Both outcomes are possible. The one that matters to your portfolio is not which of those worlds materializes, but whether you entered with a clear strategy for either.

Your process should not change because the news got exciting.

The Decision Is Yours. The Tools Are Free.

You cannot control what SPCX does next month. You can control how you enter, how much you allocate, and whether your position matches the risk profile you actually hold—not the one that felt accurate when the green numbers were filling your screen.

The largest IPO in history does not require the fastest decision. It requires the right one.